Indexed by:
Abstract:
肌氨酰胺亚硝脲(SarCNU)为亚硝脲类抗癌药,同已在临床使用的亚硝脲类药物相比,该药物具有较高的抗癌活性,同时毒性较低.本文结合国内外相关文献从药效学、药代动力学两个方面对该药物的研究进展进行综述,为SarCNU临床应用和进一步研发提供参考.
Keyword:
Reprint Author's Address:
Email:
Source :
医学综述
ISSN: 1006-2084
Year: 2008
Issue: 9
Volume: 14
Page: 1281-1284
Cited Count:
WoS CC Cited Count: 0
SCOPUS Cited Count:
ESI Highly Cited Papers on the List: 0 Unfold All
WanFang Cited Count: -1
Chinese Cited Count:
30 Days PV: 6
Affiliated Colleges: